Biotech & Pharma News & Analysis | Business 2.0
GSK Unit's Long-acting HIV Regimen Meets Phase Iiib Endpoint
Alexion to Present 16 Rare Disease Studies at ASBMR 2026
Astrazeneca Opens Kendall Square R&d Centre With $1 Billion Bet
Bayer Plans 2.2 Billion Dollar Ohio Manufacturing Site
Top 10 Biopharma Conferences In London, UK And Europe In 2026 And 2027
Astrazeneca, Daiichi Sankyo Add Summit to Datroway Combination Push
What Does Bayer's New Chief Medical Officer Appointment Signal?
What Do FDA and EMA Orphan Designations Mean for Bluerock's Cell Therapy?
NVIDIA Joins Open Protein Dataset Push for Pandemic AI in 2026
Anthropic Builds Biology Lab as Claude Moves Into Life Sciences
Outer Bio Emerges With $23M Skin Longevity Platform Backed by Lady Gaga
Merck and Moderna mRNA Cancer Vaccine Beats KEYTRUDA Alone in Phase 3 Melanoma Trial
Novo Nordisk and AWS Launch London AI Hub to Speed Drug Discovery
AI Drug Discovery Has a Data Problem — and It's More Expensive Than Anyone Admits
List of Top Upcoming Stem Cells Conferences in London, UK, EU and USA in 2026
Closing Tackles Data Loop Challenge in AI Drug Discovery in 2026
AI in Biotech & Pharma Explained: What Enterprises Need in 2026
Angelini Pharma to Acquire Catalyst in $4.1 Billion Deal
Lilly Launches LillyPod AI Factory for Drug Discovery
Gilead 2026: FDA Clears Hepcludex as First U.S. HDV Therapy